nodes	percent_of_prediction	percent_of_DWPC	metapath
Abiraterone—ALB—lung cancer	0.174	1	CbGaD
Abiraterone—ORM1—Gefitinib—lung cancer	0.0759	0.134	CbGbCtD
Abiraterone—ORM1—Erlotinib—lung cancer	0.0449	0.0793	CbGbCtD
Abiraterone—ABCC1—Paclitaxel—lung cancer	0.0375	0.0662	CbGbCtD
Abiraterone—ABCC1—Irinotecan—lung cancer	0.037	0.0653	CbGbCtD
Abiraterone—ABCC1—Vinblastine—lung cancer	0.0329	0.058	CbGbCtD
Abiraterone—ALB—Gefitinib—lung cancer	0.032	0.0564	CbGbCtD
Abiraterone—ABCC1—Etoposide—lung cancer	0.0296	0.0523	CbGbCtD
Abiraterone—ABCC1—Docetaxel—lung cancer	0.0271	0.0478	CbGbCtD
Abiraterone—ABCC1—Doxorubicin—lung cancer	0.0202	0.0357	CbGbCtD
Abiraterone—ABCC1—Methotrexate—lung cancer	0.0196	0.0346	CbGbCtD
Abiraterone—ALB—Erlotinib—lung cancer	0.0189	0.0333	CbGbCtD
Abiraterone—ALB—Irinotecan—lung cancer	0.0171	0.0301	CbGbCtD
Abiraterone—CYP2D6—Gefitinib—lung cancer	0.0157	0.0278	CbGbCtD
Abiraterone—CYP2C8—Erlotinib—lung cancer	0.0146	0.0258	CbGbCtD
Abiraterone—CYP2C8—Paclitaxel—lung cancer	0.0134	0.0236	CbGbCtD
Abiraterone—CYP2D6—Vinorelbine—lung cancer	0.0121	0.0214	CbGbCtD
Abiraterone—CYP3A4—Topotecan—lung cancer	0.0109	0.0193	CbGbCtD
Abiraterone—CYP2C8—Etoposide—lung cancer	0.0106	0.0186	CbGbCtD
Abiraterone—CYP3A4—Gefitinib—lung cancer	0.01	0.0177	CbGbCtD
Abiraterone—CYP3A4—Teniposide—lung cancer	0.00971	0.0171	CbGbCtD
Abiraterone—CYP2D6—Erlotinib—lung cancer	0.00931	0.0164	CbGbCtD
Abiraterone—ALB—Methotrexate—lung cancer	0.00903	0.0159	CbGbCtD
Abiraterone—CYP3A4—Vinorelbine—lung cancer	0.00771	0.0136	CbGbCtD
Abiraterone—CYP2D6—Vinblastine—lung cancer	0.00748	0.0132	CbGbCtD
Abiraterone—CYP3A4—Crizotinib—lung cancer	0.00614	0.0108	CbGbCtD
Abiraterone—CYP3A4—Erlotinib—lung cancer	0.00592	0.0105	CbGbCtD
Abiraterone—CYP3A4—Paclitaxel—lung cancer	0.00542	0.00957	CbGbCtD
Abiraterone—CYP3A4—Irinotecan—lung cancer	0.00535	0.00944	CbGbCtD
Abiraterone—CYP3A4—Vinblastine—lung cancer	0.00475	0.00839	CbGbCtD
Abiraterone—CYP2D6—Doxorubicin—lung cancer	0.00459	0.00811	CbGbCtD
Abiraterone—CYP3A4—Etoposide—lung cancer	0.00428	0.00756	CbGbCtD
Abiraterone—CYP3A4—Docetaxel—lung cancer	0.00392	0.00692	CbGbCtD
Abiraterone—CYP3A4—Doxorubicin—lung cancer	0.00292	0.00516	CbGbCtD
Abiraterone—Testosterone—ABCG2—lung cancer	0.000353	0.379	CrCbGaD
Abiraterone—Testosterone—CYP1A1—lung cancer	0.000277	0.297	CrCbGaD
Abiraterone—Fluid retention—Doxorubicin—lung cancer	0.000198	0.0013	CcSEcCtD
Abiraterone—Urethral disorder—Etoposide—lung cancer	0.000198	0.0013	CcSEcCtD
Abiraterone—Arrhythmia—Cisplatin—lung cancer	0.000197	0.00129	CcSEcCtD
Abiraterone—Urinary tract disorder—Paclitaxel—lung cancer	0.000196	0.00128	CcSEcCtD
Abiraterone—Anaemia—Irinotecan—lung cancer	0.000195	0.00128	CcSEcCtD
Abiraterone—Connective tissue disorder—Paclitaxel—lung cancer	0.000195	0.00127	CcSEcCtD
Abiraterone—Urethral disorder—Paclitaxel—lung cancer	0.000194	0.00127	CcSEcCtD
Abiraterone—Body temperature increased—Topotecan—lung cancer	0.000193	0.00127	CcSEcCtD
Abiraterone—Body temperature increased—Erlotinib—lung cancer	0.000191	0.00125	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Vinorelbine—lung cancer	0.000191	0.00125	CcSEcCtD
Abiraterone—Anaemia—Gemcitabine—lung cancer	0.00019	0.00125	CcSEcCtD
Abiraterone—Pneumonia—Docetaxel—lung cancer	0.000188	0.00123	CcSEcCtD
Abiraterone—Cardiac disorder—Etoposide—lung cancer	0.000187	0.00123	CcSEcCtD
Abiraterone—Infestation NOS—Docetaxel—lung cancer	0.000187	0.00123	CcSEcCtD
Abiraterone—Infestation—Docetaxel—lung cancer	0.000187	0.00123	CcSEcCtD
Abiraterone—Dyspnoea—Vinorelbine—lung cancer	0.000187	0.00122	CcSEcCtD
Abiraterone—Cough—Irinotecan—lung cancer	0.000184	0.00121	CcSEcCtD
Abiraterone—Acute coronary syndrome—Docetaxel—lung cancer	0.000184	0.00121	CcSEcCtD
Abiraterone—Cardiac disorder—Paclitaxel—lung cancer	0.000184	0.0012	CcSEcCtD
Abiraterone—Myocardial infarction—Docetaxel—lung cancer	0.000183	0.0012	CcSEcCtD
Abiraterone—Angiopathy—Etoposide—lung cancer	0.000183	0.0012	CcSEcCtD
Abiraterone—Hypertension—Irinotecan—lung cancer	0.000183	0.0012	CcSEcCtD
Abiraterone—Mediastinal disorder—Etoposide—lung cancer	0.000182	0.00119	CcSEcCtD
Abiraterone—Asthenia—Vinblastine—lung cancer	0.000181	0.00118	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Vinorelbine—lung cancer	0.000181	0.00118	CcSEcCtD
Abiraterone—Fatigue—Vinorelbine—lung cancer	0.00018	0.00118	CcSEcCtD
Abiraterone—Cough—Gemcitabine—lung cancer	0.00018	0.00118	CcSEcCtD
Abiraterone—Angiopathy—Paclitaxel—lung cancer	0.00018	0.00118	CcSEcCtD
Abiraterone—Constipation—Vinorelbine—lung cancer	0.000179	0.00117	CcSEcCtD
Abiraterone—Mediastinal disorder—Paclitaxel—lung cancer	0.000179	0.00117	CcSEcCtD
Abiraterone—Discomfort—Irinotecan—lung cancer	0.000178	0.00116	CcSEcCtD
Abiraterone—Hypertension—Gemcitabine—lung cancer	0.000178	0.00116	CcSEcCtD
Abiraterone—Anaemia—Cisplatin—lung cancer	0.000177	0.00116	CcSEcCtD
Abiraterone—Arrhythmia—Paclitaxel—lung cancer	0.000177	0.00116	CcSEcCtD
Abiraterone—Asthenia—Topotecan—lung cancer	0.000175	0.00115	CcSEcCtD
Abiraterone—Myalgia—Gemcitabine—lung cancer	0.000175	0.00115	CcSEcCtD
Abiraterone—Chest pain—Gemcitabine—lung cancer	0.000175	0.00115	CcSEcCtD
Abiraterone—Blood alkaline phosphatase increased—Doxorubicin—lung cancer	0.000174	0.00114	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	0.000174	0.00114	CcSEcCtD
Abiraterone—Asthenia—Erlotinib—lung cancer	0.000174	0.00114	CcSEcCtD
Abiraterone—Mental disorder—Paclitaxel—lung cancer	0.000174	0.00114	CcSEcCtD
Abiraterone—Discomfort—Gemcitabine—lung cancer	0.000173	0.00113	CcSEcCtD
Abiraterone—Oedema—Irinotecan—lung cancer	0.000173	0.00113	CcSEcCtD
Abiraterone—Diarrhoea—Vinblastine—lung cancer	0.000172	0.00113	CcSEcCtD
Abiraterone—Infection—Irinotecan—lung cancer	0.000171	0.00112	CcSEcCtD
Abiraterone—Oedema—Gemcitabine—lung cancer	0.000168	0.0011	CcSEcCtD
Abiraterone—Diarrhoea—Topotecan—lung cancer	0.000167	0.0011	CcSEcCtD
Abiraterone—Infection—Gemcitabine—lung cancer	0.000167	0.00109	CcSEcCtD
Abiraterone—Urinary tract disorder—Docetaxel—lung cancer	0.000166	0.00109	CcSEcCtD
Abiraterone—Diarrhoea—Erlotinib—lung cancer	0.000166	0.00108	CcSEcCtD
Abiraterone—Body temperature increased—Vinorelbine—lung cancer	0.000165	0.00108	CcSEcCtD
Abiraterone—Connective tissue disorder—Docetaxel—lung cancer	0.000165	0.00108	CcSEcCtD
Abiraterone—Urethral disorder—Docetaxel—lung cancer	0.000165	0.00108	CcSEcCtD
Abiraterone—Myalgia—Cisplatin—lung cancer	0.000163	0.00107	CcSEcCtD
Abiraterone—Skin disorder—Gemcitabine—lung cancer	0.000163	0.00107	CcSEcCtD
Abiraterone—Anaemia—Etoposide—lung cancer	0.000163	0.00106	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.000162	0.00106	CcSEcCtD
Abiraterone—Hot flush—Doxorubicin—lung cancer	0.000162	0.00106	CcSEcCtD
Abiraterone—Discomfort—Cisplatin—lung cancer	0.000161	0.00106	CcSEcCtD
Abiraterone—Menopausal symptoms—Doxorubicin—lung cancer	0.000161	0.00105	CcSEcCtD
Abiraterone—Vomiting—Vinblastine—lung cancer	0.00016	0.00105	CcSEcCtD
Abiraterone—Anaemia—Paclitaxel—lung cancer	0.000159	0.00104	CcSEcCtD
Abiraterone—Oedema—Cisplatin—lung cancer	0.000157	0.00103	CcSEcCtD
Abiraterone—Insomnia—Irinotecan—lung cancer	0.000156	0.00102	CcSEcCtD
Abiraterone—Cardiac disorder—Docetaxel—lung cancer	0.000156	0.00102	CcSEcCtD
Abiraterone—Infection—Cisplatin—lung cancer	0.000156	0.00102	CcSEcCtD
Abiraterone—Vomiting—Topotecan—lung cancer	0.000156	0.00102	CcSEcCtD
Abiraterone—Cardiac failure—Doxorubicin—lung cancer	0.000155	0.00102	CcSEcCtD
Abiraterone—Rash—Topotecan—lung cancer	0.000154	0.00101	CcSEcCtD
Abiraterone—Testosterone—ALB—lung cancer	0.000154	0.165	CrCbGaD
Abiraterone—Dermatitis—Topotecan—lung cancer	0.000154	0.00101	CcSEcCtD
Abiraterone—Vomiting—Erlotinib—lung cancer	0.000154	0.00101	CcSEcCtD
Abiraterone—Dyspnoea—Irinotecan—lung cancer	0.000154	0.00101	CcSEcCtD
Abiraterone—Cough—Etoposide—lung cancer	0.000153	0.00101	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000153	0.001	CcSEcCtD
Abiraterone—Rash—Erlotinib—lung cancer	0.000153	0.000999	CcSEcCtD
Abiraterone—Dermatitis—Erlotinib—lung cancer	0.000152	0.000998	CcSEcCtD
Abiraterone—Angiopathy—Docetaxel—lung cancer	0.000152	0.000998	CcSEcCtD
Abiraterone—Skin disorder—Cisplatin—lung cancer	0.000152	0.000997	CcSEcCtD
Abiraterone—Insomnia—Gemcitabine—lung cancer	0.000152	0.000996	CcSEcCtD
Abiraterone—Dyspepsia—Irinotecan—lung cancer	0.000152	0.000995	CcSEcCtD
Abiraterone—Hypertension—Etoposide—lung cancer	0.000152	0.000995	CcSEcCtD
Abiraterone—Mediastinal disorder—Docetaxel—lung cancer	0.000151	0.000991	CcSEcCtD
Abiraterone—Cough—Paclitaxel—lung cancer	0.00015	0.000986	CcSEcCtD
Abiraterone—Asthenia—Vinorelbine—lung cancer	0.00015	0.000983	CcSEcCtD
Abiraterone—Arrhythmia—Docetaxel—lung cancer	0.00015	0.000982	CcSEcCtD
Abiraterone—Dyspnoea—Gemcitabine—lung cancer	0.00015	0.000982	CcSEcCtD
Abiraterone—Chest pain—Etoposide—lung cancer	0.00015	0.000981	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Irinotecan—lung cancer	0.000149	0.000976	CcSEcCtD
Abiraterone—Hypertension—Paclitaxel—lung cancer	0.000149	0.000975	CcSEcCtD
Abiraterone—Fatigue—Irinotecan—lung cancer	0.000149	0.000974	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000149	0.000974	CcSEcCtD
Abiraterone—Discomfort—Etoposide—lung cancer	0.000148	0.000969	CcSEcCtD
Abiraterone—Constipation—Irinotecan—lung cancer	0.000148	0.000967	CcSEcCtD
Abiraterone—Mental disorder—Docetaxel—lung cancer	0.000147	0.000963	CcSEcCtD
Abiraterone—Testosterone—ABCB1—lung cancer	0.000147	0.158	CrCbGaD
Abiraterone—Chest pain—Paclitaxel—lung cancer	0.000147	0.000962	CcSEcCtD
Abiraterone—Myalgia—Paclitaxel—lung cancer	0.000147	0.000962	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000146	0.000955	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000145	0.00095	CcSEcCtD
Abiraterone—Discomfort—Paclitaxel—lung cancer	0.000145	0.00095	CcSEcCtD
Abiraterone—Fatigue—Gemcitabine—lung cancer	0.000145	0.000949	CcSEcCtD
Abiraterone—Constipation—Gemcitabine—lung cancer	0.000144	0.000941	CcSEcCtD
Abiraterone—Diarrhoea—Vinorelbine—lung cancer	0.000143	0.000938	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000143	0.000935	CcSEcCtD
Abiraterone—Infection—Etoposide—lung cancer	0.000143	0.000934	CcSEcCtD
Abiraterone—Oedema—Paclitaxel—lung cancer	0.000141	0.000922	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Methotrexate—lung cancer	0.000141	0.00092	CcSEcCtD
Abiraterone—Infection—Paclitaxel—lung cancer	0.00014	0.000916	CcSEcCtD
Abiraterone—Dyspnoea—Cisplatin—lung cancer	0.00014	0.000915	CcSEcCtD
Abiraterone—Skin disorder—Etoposide—lung cancer	0.000139	0.000913	CcSEcCtD
Abiraterone—Hypokalaemia—Doxorubicin—lung cancer	0.000138	0.000903	CcSEcCtD
Abiraterone—Skin disorder—Paclitaxel—lung cancer	0.000137	0.000895	CcSEcCtD
Abiraterone—Body temperature increased—Irinotecan—lung cancer	0.000136	0.000893	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Doxorubicin—lung cancer	0.000136	0.000893	CcSEcCtD
Abiraterone—Pneumonia—Methotrexate—lung cancer	0.000136	0.000888	CcSEcCtD
Abiraterone—Nasopharyngitis—Doxorubicin—lung cancer	0.000135	0.000887	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Cisplatin—lung cancer	0.000135	0.000886	CcSEcCtD
Abiraterone—Anaemia—Docetaxel—lung cancer	0.000135	0.000885	CcSEcCtD
Abiraterone—Infestation NOS—Methotrexate—lung cancer	0.000135	0.000883	CcSEcCtD
Abiraterone—Infestation—Methotrexate—lung cancer	0.000135	0.000883	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Doxorubicin—lung cancer	0.000134	0.000875	CcSEcCtD
Abiraterone—Vomiting—Vinorelbine—lung cancer	0.000133	0.000871	CcSEcCtD
Abiraterone—Body temperature increased—Gemcitabine—lung cancer	0.000133	0.00087	CcSEcCtD
Abiraterone—Rash—Vinorelbine—lung cancer	0.000132	0.000864	CcSEcCtD
Abiraterone—Dermatitis—Vinorelbine—lung cancer	0.000132	0.000863	CcSEcCtD
Abiraterone—Haematuria—Methotrexate—lung cancer	0.000129	0.000842	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000128	0.00084	CcSEcCtD
Abiraterone—Dyspnoea—Etoposide—lung cancer	0.000128	0.000838	CcSEcCtD
Abiraterone—Cough—Docetaxel—lung cancer	0.000128	0.000835	CcSEcCtD
Abiraterone—Insomnia—Paclitaxel—lung cancer	0.000127	0.000834	CcSEcCtD
Abiraterone—Hypertension—Docetaxel—lung cancer	0.000126	0.000827	CcSEcCtD
Abiraterone—Dyspnoea—Paclitaxel—lung cancer	0.000125	0.000822	CcSEcCtD
Abiraterone—Chest pain—Docetaxel—lung cancer	0.000124	0.000815	CcSEcCtD
Abiraterone—Myalgia—Docetaxel—lung cancer	0.000124	0.000815	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Etoposide—lung cancer	0.000124	0.000812	CcSEcCtD
Abiraterone—Dyspepsia—Paclitaxel—lung cancer	0.000124	0.000811	CcSEcCtD
Abiraterone—Body temperature increased—Cisplatin—lung cancer	0.000124	0.000811	CcSEcCtD
Abiraterone—Asthenia—Irinotecan—lung cancer	0.000124	0.000811	CcSEcCtD
Abiraterone—Fatigue—Etoposide—lung cancer	0.000124	0.000811	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000124	0.000809	CcSEcCtD
Abiraterone—Constipation—Etoposide—lung cancer	0.000123	0.000804	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000122	0.000797	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000121	0.000796	CcSEcCtD
Abiraterone—Fatigue—Paclitaxel—lung cancer	0.000121	0.000795	CcSEcCtD
Abiraterone—Pollakiuria—Doxorubicin—lung cancer	0.000121	0.000792	CcSEcCtD
Abiraterone—Asthenia—Gemcitabine—lung cancer	0.000121	0.00079	CcSEcCtD
Abiraterone—Constipation—Paclitaxel—lung cancer	0.00012	0.000788	CcSEcCtD
Abiraterone—Urinary tract disorder—Methotrexate—lung cancer	0.00012	0.000783	CcSEcCtD
Abiraterone—Oedema—Docetaxel—lung cancer	0.000119	0.000781	CcSEcCtD
Abiraterone—Urethral disorder—Methotrexate—lung cancer	0.000119	0.000777	CcSEcCtD
Abiraterone—Infection—Docetaxel—lung cancer	0.000119	0.000776	CcSEcCtD
Abiraterone—Hyperglycaemia—Doxorubicin—lung cancer	0.000118	0.000773	CcSEcCtD
Abiraterone—Diarrhoea—Irinotecan—lung cancer	0.000118	0.000773	CcSEcCtD
Abiraterone—Pneumonia—Doxorubicin—lung cancer	0.000117	0.000769	CcSEcCtD
Abiraterone—Infestation NOS—Doxorubicin—lung cancer	0.000117	0.000765	CcSEcCtD
Abiraterone—Infestation—Doxorubicin—lung cancer	0.000117	0.000765	CcSEcCtD
Abiraterone—Skin disorder—Docetaxel—lung cancer	0.000116	0.000759	CcSEcCtD
Abiraterone—Diarrhoea—Gemcitabine—lung cancer	0.000115	0.000753	CcSEcCtD
Abiraterone—Body temperature increased—Etoposide—lung cancer	0.000113	0.000743	CcSEcCtD
Abiraterone—Urinary tract infection—Doxorubicin—lung cancer	0.000113	0.000743	CcSEcCtD
Abiraterone—Asthenia—Cisplatin—lung cancer	0.000112	0.000736	CcSEcCtD
Abiraterone—Cardiac disorder—Methotrexate—lung cancer	0.000112	0.000736	CcSEcCtD
Abiraterone—Haematuria—Doxorubicin—lung cancer	0.000111	0.000729	CcSEcCtD
Abiraterone—Body temperature increased—Paclitaxel—lung cancer	0.000111	0.000729	CcSEcCtD
Abiraterone—Angiopathy—Methotrexate—lung cancer	0.00011	0.000719	CcSEcCtD
Abiraterone—Vomiting—Irinotecan—lung cancer	0.00011	0.000719	CcSEcCtD
Abiraterone—Mediastinal disorder—Methotrexate—lung cancer	0.000109	0.000714	CcSEcCtD
Abiraterone—Rash—Irinotecan—lung cancer	0.000109	0.000713	CcSEcCtD
Abiraterone—Dermatitis—Irinotecan—lung cancer	0.000109	0.000712	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000109	0.000712	CcSEcCtD
Abiraterone—Insomnia—Docetaxel—lung cancer	0.000108	0.000707	CcSEcCtD
Abiraterone—Diarrhoea—Cisplatin—lung cancer	0.000107	0.000702	CcSEcCtD
Abiraterone—Vomiting—Gemcitabine—lung cancer	0.000107	0.0007	CcSEcCtD
Abiraterone—Dyspnoea—Docetaxel—lung cancer	0.000106	0.000697	CcSEcCtD
Abiraterone—Mental disorder—Methotrexate—lung cancer	0.000106	0.000694	CcSEcCtD
Abiraterone—Rash—Gemcitabine—lung cancer	0.000106	0.000694	CcSEcCtD
Abiraterone—Dermatitis—Gemcitabine—lung cancer	0.000106	0.000694	CcSEcCtD
Abiraterone—Dyspepsia—Docetaxel—lung cancer	0.000105	0.000688	CcSEcCtD
Abiraterone—Urinary tract disorder—Doxorubicin—lung cancer	0.000103	0.000678	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Docetaxel—lung cancer	0.000103	0.000675	CcSEcCtD
Abiraterone—Asthenia—Etoposide—lung cancer	0.000103	0.000675	CcSEcCtD
Abiraterone—Connective tissue disorder—Doxorubicin—lung cancer	0.000103	0.000674	CcSEcCtD
Abiraterone—Fatigue—Docetaxel—lung cancer	0.000103	0.000674	CcSEcCtD
Abiraterone—Urethral disorder—Doxorubicin—lung cancer	0.000103	0.000673	CcSEcCtD
Abiraterone—Constipation—Docetaxel—lung cancer	0.000102	0.000668	CcSEcCtD
Abiraterone—Asthenia—Paclitaxel—lung cancer	0.000101	0.000661	CcSEcCtD
Abiraterone—Vomiting—Cisplatin—lung cancer	9.96e-05	0.000652	CcSEcCtD
Abiraterone—Rash—Cisplatin—lung cancer	9.88e-05	0.000647	CcSEcCtD
Abiraterone—Dermatitis—Cisplatin—lung cancer	9.87e-05	0.000646	CcSEcCtD
Abiraterone—Diarrhoea—Etoposide—lung cancer	9.82e-05	0.000643	CcSEcCtD
Abiraterone—Anaemia—Methotrexate—lung cancer	9.74e-05	0.000638	CcSEcCtD
Abiraterone—Cardiac disorder—Doxorubicin—lung cancer	9.72e-05	0.000637	CcSEcCtD
Abiraterone—Diarrhoea—Paclitaxel—lung cancer	9.63e-05	0.000631	CcSEcCtD
Abiraterone—Angiopathy—Doxorubicin—lung cancer	9.51e-05	0.000623	CcSEcCtD
Abiraterone—Mediastinal disorder—Doxorubicin—lung cancer	9.44e-05	0.000619	CcSEcCtD
Abiraterone—Body temperature increased—Docetaxel—lung cancer	9.43e-05	0.000618	CcSEcCtD
Abiraterone—Arrhythmia—Doxorubicin—lung cancer	9.36e-05	0.000613	CcSEcCtD
Abiraterone—Cough—Methotrexate—lung cancer	9.19e-05	0.000602	CcSEcCtD
Abiraterone—Mental disorder—Doxorubicin—lung cancer	9.18e-05	0.000601	CcSEcCtD
Abiraterone—Vomiting—Etoposide—lung cancer	9.13e-05	0.000598	CcSEcCtD
Abiraterone—Rash—Etoposide—lung cancer	9.05e-05	0.000593	CcSEcCtD
Abiraterone—Dermatitis—Etoposide—lung cancer	9.04e-05	0.000592	CcSEcCtD
Abiraterone—Myalgia—Methotrexate—lung cancer	8.97e-05	0.000587	CcSEcCtD
Abiraterone—Chest pain—Methotrexate—lung cancer	8.97e-05	0.000587	CcSEcCtD
Abiraterone—Vomiting—Paclitaxel—lung cancer	8.95e-05	0.000586	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	8.91e-05	0.000583	CcSEcCtD
Abiraterone—Rash—Paclitaxel—lung cancer	8.87e-05	0.000581	CcSEcCtD
Abiraterone—Dermatitis—Paclitaxel—lung cancer	8.87e-05	0.000581	CcSEcCtD
Abiraterone—Discomfort—Methotrexate—lung cancer	8.86e-05	0.00058	CcSEcCtD
Abiraterone—Asthenia—Docetaxel—lung cancer	8.56e-05	0.000561	CcSEcCtD
Abiraterone—Infection—Methotrexate—lung cancer	8.54e-05	0.000559	CcSEcCtD
Abiraterone—Anaemia—Doxorubicin—lung cancer	8.43e-05	0.000552	CcSEcCtD
Abiraterone—Skin disorder—Methotrexate—lung cancer	8.35e-05	0.000547	CcSEcCtD
Abiraterone—Diarrhoea—Docetaxel—lung cancer	8.16e-05	0.000535	CcSEcCtD
Abiraterone—Cough—Doxorubicin—lung cancer	7.96e-05	0.000521	CcSEcCtD
Abiraterone—Hypertension—Doxorubicin—lung cancer	7.88e-05	0.000516	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Methotrexate—lung cancer	7.83e-05	0.000513	CcSEcCtD
Abiraterone—Insomnia—Methotrexate—lung cancer	7.78e-05	0.000509	CcSEcCtD
Abiraterone—Chest pain—Doxorubicin—lung cancer	7.77e-05	0.000509	CcSEcCtD
Abiraterone—Myalgia—Doxorubicin—lung cancer	7.77e-05	0.000509	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	7.71e-05	0.000505	CcSEcCtD
Abiraterone—Discomfort—Doxorubicin—lung cancer	7.67e-05	0.000503	CcSEcCtD
Abiraterone—Dyspnoea—Methotrexate—lung cancer	7.66e-05	0.000502	CcSEcCtD
Abiraterone—Vomiting—Docetaxel—lung cancer	7.58e-05	0.000497	CcSEcCtD
Abiraterone—Dyspepsia—Methotrexate—lung cancer	7.57e-05	0.000496	CcSEcCtD
Abiraterone—Rash—Docetaxel—lung cancer	7.52e-05	0.000493	CcSEcCtD
Abiraterone—Dermatitis—Docetaxel—lung cancer	7.51e-05	0.000492	CcSEcCtD
Abiraterone—Oedema—Doxorubicin—lung cancer	7.44e-05	0.000488	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Methotrexate—lung cancer	7.42e-05	0.000486	CcSEcCtD
Abiraterone—Fatigue—Methotrexate—lung cancer	7.41e-05	0.000485	CcSEcCtD
Abiraterone—Infection—Doxorubicin—lung cancer	7.4e-05	0.000484	CcSEcCtD
Abiraterone—Skin disorder—Doxorubicin—lung cancer	7.23e-05	0.000474	CcSEcCtD
Abiraterone—Body temperature increased—Methotrexate—lung cancer	6.8e-05	0.000445	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Doxorubicin—lung cancer	6.78e-05	0.000444	CcSEcCtD
Abiraterone—Insomnia—Doxorubicin—lung cancer	6.73e-05	0.000441	CcSEcCtD
Abiraterone—Dyspnoea—Doxorubicin—lung cancer	6.64e-05	0.000435	CcSEcCtD
Abiraterone—Dyspepsia—Doxorubicin—lung cancer	6.55e-05	0.000429	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Doxorubicin—lung cancer	6.43e-05	0.000421	CcSEcCtD
Abiraterone—Fatigue—Doxorubicin—lung cancer	6.42e-05	0.00042	CcSEcCtD
Abiraterone—Constipation—Doxorubicin—lung cancer	6.37e-05	0.000417	CcSEcCtD
Abiraterone—Asthenia—Methotrexate—lung cancer	6.17e-05	0.000404	CcSEcCtD
Abiraterone—Body temperature increased—Doxorubicin—lung cancer	5.88e-05	0.000385	CcSEcCtD
Abiraterone—Diarrhoea—Methotrexate—lung cancer	5.88e-05	0.000385	CcSEcCtD
Abiraterone—Vomiting—Methotrexate—lung cancer	5.47e-05	0.000358	CcSEcCtD
Abiraterone—Rash—Methotrexate—lung cancer	5.42e-05	0.000355	CcSEcCtD
Abiraterone—Dermatitis—Methotrexate—lung cancer	5.42e-05	0.000355	CcSEcCtD
Abiraterone—Asthenia—Doxorubicin—lung cancer	5.34e-05	0.00035	CcSEcCtD
Abiraterone—Diarrhoea—Doxorubicin—lung cancer	5.09e-05	0.000334	CcSEcCtD
Abiraterone—Vomiting—Doxorubicin—lung cancer	4.73e-05	0.00031	CcSEcCtD
Abiraterone—Rash—Doxorubicin—lung cancer	4.69e-05	0.000307	CcSEcCtD
Abiraterone—Dermatitis—Doxorubicin—lung cancer	4.69e-05	0.000307	CcSEcCtD
Abiraterone—ALB—Hemostasis—PIK3CG—lung cancer	1.08e-05	0.000102	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.08e-05	0.000102	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—HSD17B10—lung cancer	1.08e-05	0.000102	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—EGF—lung cancer	1.07e-05	0.000101	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GSTA4—lung cancer	1.06e-05	0.000101	CbGpPWpGaD
Abiraterone—ABCC1—Disease—APOA1—lung cancer	1.05e-05	0.0001	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ALDOA—lung cancer	1.04e-05	9.82e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GSTA2—lung cancer	1.03e-05	9.79e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ALDOA—lung cancer	1.03e-05	9.77e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CYP1A1—lung cancer	1.03e-05	9.76e-05	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PIK3CB—lung cancer	1.02e-05	9.71e-05	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—APOA1—lung cancer	1.02e-05	9.71e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—ERCC2—lung cancer	1.02e-05	9.68e-05	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PTGS2—lung cancer	1.02e-05	9.62e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—NCOA3—lung cancer	1.01e-05	9.54e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—CREBBP—lung cancer	1e-05	9.49e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—NCOA3—lung cancer	1e-05	9.48e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CKB—lung cancer	1e-05	9.48e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GSTA1—lung cancer	9.97e-06	9.45e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	9.89e-06	9.37e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ABCC3—lung cancer	9.86e-06	9.34e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	9.83e-06	9.32e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ADCY1—lung cancer	9.79e-06	9.28e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ABCG2—lung cancer	9.79e-06	9.28e-05	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—PIK3CA—lung cancer	9.79e-06	9.28e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ADCY1—lung cancer	9.73e-06	9.23e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ABCG2—lung cancer	9.73e-06	9.23e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—KIT—lung cancer	9.63e-06	9.13e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—APC—lung cancer	9.63e-06	9.13e-05	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—AKT1—lung cancer	9.61e-06	9.11e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—HPGDS—lung cancer	9.6e-06	9.1e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ENO2—lung cancer	9.6e-06	9.1e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—AKR1C1—lung cancer	9.55e-06	9.05e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ENO2—lung cancer	9.55e-06	9.05e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—HPGDS—lung cancer	9.55e-06	9.05e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PPP2R1B—lung cancer	9.54e-06	9.04e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—EGF—lung cancer	9.52e-06	9.02e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—PIK3CD—lung cancer	9.49e-06	9e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PPP2R1B—lung cancer	9.49e-06	8.99e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—lung cancer	9.41e-06	8.92e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTM2—lung cancer	9.4e-06	8.91e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CNDP2—lung cancer	9.4e-06	8.91e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—POMC—lung cancer	9.36e-06	8.87e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GSTT1—lung cancer	9.31e-06	8.82e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—UGT1A1—lung cancer	9.27e-06	8.78e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GSTT1—lung cancer	9.26e-06	8.77e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GCLC—lung cancer	9.2e-06	8.72e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYP2A6—lung cancer	9.2e-06	8.72e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	9.17e-06	8.69e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GCLC—lung cancer	9.15e-06	8.67e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP2A6—lung cancer	9.15e-06	8.67e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—MTMR3—lung cancer	9.15e-06	8.67e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	9.12e-06	8.64e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—BRAF—lung cancer	9.05e-06	8.58e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—IL6R—lung cancer	8.94e-06	8.47e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GNG11—lung cancer	8.94e-06	8.47e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CREBBP—lung cancer	8.93e-06	8.46e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PGAM1—lung cancer	8.92e-06	8.45e-05	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PTEN—lung cancer	8.85e-06	8.39e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—APOA1—lung cancer	8.83e-06	8.37e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ENO1—lung cancer	8.73e-06	8.27e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	8.69e-06	8.24e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ENO1—lung cancer	8.68e-06	8.22e-05	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—CREBBP—lung cancer	8.67e-06	8.22e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	8.64e-06	8.19e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—lung cancer	8.58e-06	8.13e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MAP2K1—lung cancer	8.52e-06	8.08e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ALDOA—lung cancer	8.51e-06	8.07e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP2A7—lung cancer	8.5e-06	8.06e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—RAF1—lung cancer	8.48e-06	8.03e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PIK3CD—lung cancer	8.47e-06	8.02e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	8.46e-06	8.02e-05	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—EP300—lung cancer	8.44e-06	8e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—SDC4—lung cancer	8.32e-06	7.89e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—PIK3CB—lung cancer	8.28e-06	7.84e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—NCOA3—lung cancer	8.26e-06	7.83e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PIK3CG—lung cancer	8.06e-06	7.64e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ADCY1—lung cancer	8.04e-06	7.62e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ABCG2—lung cancer	8.04e-06	7.62e-05	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—AKT1—lung cancer	8e-06	7.58e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—HPGDS—lung cancer	7.88e-06	7.47e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ENO2—lung cancer	7.88e-06	7.47e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PPP2R1B—lung cancer	7.83e-06	7.42e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYP2E1—lung cancer	7.83e-06	7.42e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP2E1—lung cancer	7.78e-06	7.37e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—NQO1—lung cancer	7.74e-06	7.33e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—NQO1—lung cancer	7.69e-06	7.29e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—POMC—lung cancer	7.68e-06	7.28e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GSTT1—lung cancer	7.64e-06	7.24e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—IL2—lung cancer	7.6e-06	7.2e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MDM2—lung cancer	7.58e-06	7.19e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—RRM1—lung cancer	7.58e-06	7.18e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTA3—lung cancer	7.58e-06	7.18e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	7.58e-06	7.18e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—RAF1—lung cancer	7.56e-06	7.16e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GCLC—lung cancer	7.56e-06	7.16e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP2A6—lung cancer	7.56e-06	7.16e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	7.53e-06	7.14e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	7.51e-06	7.12e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CREBBP—lung cancer	7.48e-06	7.09e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—ERBB2—lung cancer	7.48e-06	7.09e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	7.47e-06	7.08e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MTOR—lung cancer	7.38e-06	6.99e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PIK3CB—lung cancer	7.38e-06	6.99e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CD4—lung cancer	7.37e-06	6.98e-05	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—RAF1—lung cancer	7.34e-06	6.95e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PTGS2—lung cancer	7.31e-06	6.93e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ENO1—lung cancer	7.16e-06	6.79e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—B4GALT5—lung cancer	7.13e-06	6.75e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PIK3CD—lung cancer	7.09e-06	6.72e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—ALB—lung cancer	7e-06	6.63e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—STK11—lung cancer	6.98e-06	6.61e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—STK11—lung cancer	6.94e-06	6.57e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTA4—lung cancer	6.93e-06	6.57e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—EP300—lung cancer	6.82e-06	6.46e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTA2—lung cancer	6.76e-06	6.4e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—SRC—lung cancer	6.63e-06	6.29e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	6.55e-06	6.21e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTA1—lung cancer	6.52e-06	6.18e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PTEN—lung cancer	6.51e-06	6.17e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—VEGFA—lung cancer	6.46e-06	6.12e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GSTP1—lung cancer	6.45e-06	6.12e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ABCC3—lung cancer	6.45e-06	6.11e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP2E1—lung cancer	6.42e-06	6.09e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GSTP1—lung cancer	6.42e-06	6.08e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CDKN1A—lung cancer	6.39e-06	6.06e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—NRAS—lung cancer	6.38e-06	6.05e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PTEN—lung cancer	6.38e-06	6.04e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—NQO1—lung cancer	6.35e-06	6.02e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CAT—lung cancer	6.28e-06	5.95e-05	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PIK3CA—lung cancer	6.24e-06	5.92e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CAT—lung cancer	6.24e-06	5.92e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	6.24e-06	5.92e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—AKR1C1—lung cancer	6.24e-06	5.92e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—EP300—lung cancer	6.21e-06	5.88e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PIK3CB—lung cancer	6.18e-06	5.86e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PTGS2—lung cancer	6.12e-06	5.8e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—MAPK3—lung cancer	6.11e-06	5.79e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ABCB1—lung cancer	6.11e-06	5.79e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—EP300—lung cancer	6.08e-06	5.76e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ABCB1—lung cancer	6.07e-06	5.76e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—UGT1A1—lung cancer	6.06e-06	5.74e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—TYMS—lung cancer	6e-06	5.69e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—TYMS—lung cancer	5.97e-06	5.65e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GSTM1—lung cancer	5.93e-06	5.62e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—SRC—lung cancer	5.91e-06	5.6e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GSTM1—lung cancer	5.9e-06	5.59e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GNG11—lung cancer	5.84e-06	5.54e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—STK11—lung cancer	5.73e-06	5.43e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—STAT3—lung cancer	5.7e-06	5.4e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—NRAS—lung cancer	5.69e-06	5.39e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYP1A1—lung cancer	5.62e-06	5.33e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP1A1—lung cancer	5.59e-06	5.3e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ERCC2—lung cancer	5.58e-06	5.29e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ALDOA—lung cancer	5.56e-06	5.27e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ERCC2—lung cancer	5.54e-06	5.25e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—KRAS—lung cancer	5.49e-06	5.2e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MAPK3—lung cancer	5.45e-06	5.16e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NCOA3—lung cancer	5.4e-06	5.12e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PTEN—lung cancer	5.34e-06	5.06e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MYC—lung cancer	5.3e-06	5.02e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GSTP1—lung cancer	5.3e-06	5.02e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ADCY1—lung cancer	5.25e-06	4.98e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ABCG2—lung cancer	5.25e-06	4.98e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—EGFR—lung cancer	5.18e-06	4.91e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CAT—lung cancer	5.16e-06	4.89e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—HPGDS—lung cancer	5.15e-06	4.88e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ENO2—lung cancer	5.15e-06	4.88e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PPP2R1B—lung cancer	5.12e-06	4.85e-05	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—AKT1—lung cancer	5.1e-06	4.84e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—EP300—lung cancer	5.09e-06	4.83e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—PIK3CA—lung cancer	5.04e-06	4.78e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ABCB1—lung cancer	5.02e-06	4.75e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTT1—lung cancer	5e-06	4.74e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GCLC—lung cancer	4.94e-06	4.68e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP2A6—lung cancer	4.94e-06	4.68e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—TYMS—lung cancer	4.93e-06	4.67e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—KRAS—lung cancer	4.9e-06	4.64e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—TP53—lung cancer	4.88e-06	4.63e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GSTM1—lung cancer	4.87e-06	4.61e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—APOA1—lung cancer	4.82e-06	4.57e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—APOA1—lung cancer	4.8e-06	4.55e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ENO1—lung cancer	4.68e-06	4.44e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—HRAS—lung cancer	4.67e-06	4.42e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.62e-06	4.38e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP1A1—lung cancer	4.62e-06	4.37e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.59e-06	4.35e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ERCC2—lung cancer	4.58e-06	4.34e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PIK3CA—lung cancer	4.5e-06	4.26e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PIK3CG—lung cancer	4.4e-06	4.17e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PIK3CG—lung cancer	4.38e-06	4.15e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP2E1—lung cancer	4.2e-06	3.98e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—POMC—lung cancer	4.19e-06	3.97e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—POMC—lung cancer	4.17e-06	3.95e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—HRAS—lung cancer	4.16e-06	3.94e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NQO1—lung cancer	4.15e-06	3.94e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—AKT1—lung cancer	4.12e-06	3.91e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CREBBP—lung cancer	4.08e-06	3.87e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CREBBP—lung cancer	4.06e-06	3.85e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—IL6—lung cancer	3.98e-06	3.78e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—APOA1—lung cancer	3.96e-06	3.75e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PIK3CD—lung cancer	3.87e-06	3.67e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PIK3CD—lung cancer	3.85e-06	3.65e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ALB—lung cancer	3.82e-06	3.62e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PIK3CA—lung cancer	3.77e-06	3.57e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—STK11—lung cancer	3.74e-06	3.55e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—AKT1—lung cancer	3.67e-06	3.48e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PIK3CG—lung cancer	3.62e-06	3.43e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTP1—lung cancer	3.46e-06	3.28e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—POMC—lung cancer	3.44e-06	3.26e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PIK3CB—lung cancer	3.37e-06	3.2e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CAT—lung cancer	3.37e-06	3.19e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PIK3CB—lung cancer	3.36e-06	3.18e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CREBBP—lung cancer	3.35e-06	3.18e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PTGS2—lung cancer	3.34e-06	3.17e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PTGS2—lung cancer	3.32e-06	3.15e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ABCB1—lung cancer	3.28e-06	3.11e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—TYMS—lung cancer	3.22e-06	3.05e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTM1—lung cancer	3.18e-06	3.02e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PIK3CD—lung cancer	3.18e-06	3.01e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ALB—lung cancer	3.14e-06	2.97e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—AKT1—lung cancer	3.08e-06	2.92e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP1A1—lung cancer	3.02e-06	2.86e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ERCC2—lung cancer	2.99e-06	2.84e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PTEN—lung cancer	2.92e-06	2.76e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PTEN—lung cancer	2.9e-06	2.75e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—EP300—lung cancer	2.78e-06	2.64e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PIK3CB—lung cancer	2.77e-06	2.63e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—EP300—lung cancer	2.77e-06	2.62e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PTGS2—lung cancer	2.74e-06	2.6e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—APOA1—lung cancer	2.59e-06	2.45e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PTEN—lung cancer	2.39e-06	2.27e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PIK3CG—lung cancer	2.36e-06	2.24e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—EP300—lung cancer	2.28e-06	2.16e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—POMC—lung cancer	2.25e-06	2.13e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CREBBP—lung cancer	2.19e-06	2.08e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PIK3CD—lung cancer	2.08e-06	1.97e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PIK3CA—lung cancer	2.06e-06	1.95e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ALB—lung cancer	2.05e-06	1.94e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PIK3CA—lung cancer	2.05e-06	1.94e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PIK3CB—lung cancer	1.81e-06	1.72e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PTGS2—lung cancer	1.79e-06	1.7e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PIK3CA—lung cancer	1.69e-06	1.6e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—AKT1—lung cancer	1.68e-06	1.59e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—AKT1—lung cancer	1.67e-06	1.58e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PTEN—lung cancer	1.57e-06	1.48e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—EP300—lung cancer	1.49e-06	1.41e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—AKT1—lung cancer	1.38e-06	1.31e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PIK3CA—lung cancer	1.1e-06	1.05e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—AKT1—lung cancer	9.02e-07	8.55e-06	CbGpPWpGaD
